Both companies will be in the range of their transaction value until the merger is completed ( US$ 9.06 Allkem = 1:1 ratio - at Livent Current price/ 2.406 ). Who pays more than he would have to pay afterwards? Although this carries a risk of missing the rise that could or will follow the merger.
Only with or after the merger, I personally see clear opportunities for a sharp rise. As far as short loads are concerned, many investors are now playing into the hands of these short sellers by leaving the previous price - holding the share. The listing or listing on the US stock exchange alone - the financially strongest stock exchange in the world - opens up completely different price development opportunities.
If one sees in addition still the steps of Chile - possibly still Bolivia and Mexico - the raw material protectionism to force - which will hit also Albemarle, becomes clear that other actors of larger interest become. Here Livent and Allkem are in the starting blocks and in the right position to offer themselves broadly.
AKE Price at posting:
$14.92 Sentiment: Buy Disclosure: Held